{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T05:08:09Z","timestamp":1713935289855},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,22]]},"DOI":"10.7759\/cureus.52716","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T12:11:32Z","timestamp":1705925492000},"source":"Crossref","is-referenced-by-count":1,"title":["A Complete Response to Pembrolizumab in Malignant Peritoneal Mesothelioma: A Case Report"],"prefix":"10.7759","author":[{"given":"Maria","family":"Bairos Menezes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Pedroso de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Dun\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"In\u00e1cio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Dinis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl345","article-title":"Epidemiology of peritoneal mesothelioma: a review","volume":"18","author":"Boffetta P","year":"2007","unstructured":"Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007, 18:985-90. 10.1093\/annonc\/mdl345","journal-title":"Ann Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.21037\/asj-22-37","article-title":"An update in malignant peritoneal mesothelioma diagnosis and treatment\u2014a narrative review","volume":"3","author":"Newland JJ","year":"2023","unstructured":"Newland JJ, Molin MD, Terhune JH. An update in malignant peritoneal mesothelioma diagnosis and treatment\u2014a narrative review. AME Surg J. 2023, 3:36. 10.21037\/asj-22-37","journal-title":"AME Surg J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15761\/ghe.1000152","article-title":"Malignant peritoneal mesothelioma-a diagnostic and therapeutic challenge: a case report","volume":"3","author":"Singh H","year":"2018","unstructured":"Singh H, Maric L, sharma N, A. Bejarano P, Ukleja A. Malignant peritoneal mesothelioma-a diagnostic and therapeutic challenge: a case report. Gastroenterol Hepatol Endosc. 2018, 3:4-6. 10.15761\/ghe.1000152","journal-title":"Gastroenterol Hepatol Endosc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2019.02.001","article-title":"Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays","volume":"87","author":"Chapel DB","year":"2019","unstructured":"Chapel DB, Stewart R, Furtado LV, Husain AN, Krausz T, Deftereos G. Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays. Hum Pathol. 2019, 87:11-7. 10.1016\/j.humpath.2019.02.001","journal-title":"Hum Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2023.2627","article-title":"Immunotherapy in malignant peritoneal mesothelioma (review)","volume":"18","author":"Alaklabi S","year":"2023","unstructured":"Alaklabi S, Roy AM, Skitzki JJ, Iyer R. Immunotherapy in malignant peritoneal mesothelioma (review). Mol Clin Oncol. 2023, 18:31-3. 10.3892\/mco.2023.2627","journal-title":"Mol Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.8565","article-title":"Phase II trial of pembrolizumab (P) in patients (pts) with previously-treated mesothelioma (MM)","volume":"36","author":"Desai A","year":"2018","unstructured":"Desai A, Karrison T, Rose B, et al.. Phase II trial of pembrolizumab (P) in patients (pts) with previously-treated mesothelioma (MM). J Clin Oncol. 2018, 36:8565. 10.1200\/JCO.2018.36.15_suppl.8565","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.2526","article-title":"Clinical outcomes associated with pembrolizumab monotherapy among adults with diffuse malignant peritoneal mesothelioma","volume":"6","author":"Marmarelis ME","year":"2023","unstructured":"Marmarelis ME, Wang X, Roshkovan L, et al.. Clinical outcomes associated with pembrolizumab monotherapy among adults with diffuse malignant peritoneal mesothelioma. JAMA Netw Open. 2023, 6:e232526. 10.1001\/jamanetworkopen.2023.2526","journal-title":"JAMA Netw Open"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.19934","article-title":"Clinical efficacy of immune checkpoint inhibitors in patients with advanced malignant peritoneal mesothelioma","volume":"4","author":"Raghav K","year":"2021","unstructured":"Raghav K, Liu S, Overman M, Morani A, Willette A, Fournier K, Varadhachary G. Clinical efficacy of immune checkpoint inhibitors in patients with advanced malignant peritoneal mesothelioma. JAMA Netw Open. 2021, 4:e2119934. 10.1001\/jamanetworkopen.2021.19934","journal-title":"JAMA Netw Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/221698-a-complete-response-to-pembrolizumab-in-malignant-peritoneal-mesothelioma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:30Z","timestamp":1707509550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/221698-a-complete-response-to-pembrolizumab-in-malignant-peritoneal-mesothelioma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.52716","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,22]]}}}